Skip to main content

68th Annual Scientific Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Red Recording

Sig Meeting

Karin Hygge-Blakeman, n/a

Pfizer AB., Stockholm, Sweden

Poster(s):

(E 64) Patient-reported outcomes (PROs) for patients prescribed only acute or preventive rimegepant for migraine care via telemedicine at initial consultation and quarterly check-in
(T 18) Treatment outcomes with rimegepant versus other standard of care acute migraine medications in the observational CONFIDENCE study